Data is not available at this time.
American Healthcare REIT, Inc. (AHR) operates as a real estate investment trust (REIT) specializing in healthcare-related properties, including senior housing, medical office buildings, and skilled nursing facilities. The company generates revenue primarily through long-term leases and rental income from its diversified portfolio, which serves healthcare providers and operators. AHR’s focus on essential healthcare real estate positions it in a defensive sector with stable demand, driven by demographic trends such as an aging population and increasing healthcare needs. The REIT’s market position is reinforced by its strategic acquisitions and partnerships with leading healthcare operators, ensuring occupancy stability and cash flow visibility. By maintaining a geographically diversified asset base, AHR mitigates regional economic risks while capitalizing on localized demand for healthcare services. Its business model aligns with the growing need for specialized healthcare infrastructure, offering investors exposure to a resilient niche within the broader real estate market.
AHR reported revenue of $2.07 billion for FY 2024, reflecting its substantial portfolio scale. However, the company posted a net loss of $37.8 million, with diluted EPS of -$0.29, indicating margin pressures, possibly from higher operating costs or interest expenses. Operating cash flow stood at $176.1 million, suggesting core operations remain cash-generative despite profitability challenges. Capital expenditures of $91.9 million highlight ongoing investments in property maintenance and growth.
The negative net income raises questions about AHR’s near-term earnings power, though its operating cash flow demonstrates underlying cash generation capability. The REIT’s ability to cover its dividend—distributing $0.93 per share—will depend on stabilizing profitability and managing leverage. Capital efficiency metrics are not fully clear without ROIC or FFO data, but the sizable debt load suggests careful capital allocation is critical.
AHR’s balance sheet shows $76.7 million in cash against $1.87 billion in total debt, indicating a leveraged position. The debt-to-equity ratio is not provided, but the high absolute debt level warrants scrutiny, especially given rising interest rates. Liquidity appears manageable, with operating cash flow supporting near-term obligations, but refinancing risks may persist in a tight credit environment.
Growth prospects hinge on AHR’s ability to expand its healthcare property portfolio amid competitive demand. The $0.93 per share dividend implies a yield that may appeal to income-focused investors, but sustainability depends on improving profitability and cash flow. Demographic tailwinds in healthcare demand could support long-term growth, though near-term execution risks remain.
Market expectations for AHR likely balance its sector resilience against financial leverage and earnings volatility. The REIT’s valuation will be influenced by cap rates for healthcare properties, interest rate trends, and its ability to stabilize margins. Investors may weigh its dividend yield against peers while assessing leverage-adjusted returns.
AHR’s strategic advantage lies in its focus on mission-critical healthcare real estate, which offers recession-resistant cash flows. The outlook depends on operational execution, debt management, and capital recycling. Success in optimizing its asset mix and lease structures could enhance long-term value, though macroeconomic and sector-specific headwinds pose risks.
Company filings (CIK: 0001632970), reported financials for FY 2024
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |